Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celine Hoyek

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Targeting RAS in gastrointestinal malignanciesOluseyi Abidoye, Celine Hoyek, Tanios Bekaii-Saab
Expert Opinion on Investigational Drugs|February 28, 2025
Tucatinib in the treatment of HER2-overexpressing gastrointestinal cancers: current insights and future prospectsCeline Hoyek, Binbin Zheng-Lin, Jeremy Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 4, 2026
Successful Management of BRAF V600E-Mutated Metastatic Colorectal Cancer With Liver Dysfunction Using Encorafenib-Based TherapyCeline Hoyek, Angelo Pirozzi, Kelley Rone, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence?Celine Hoyek, Angelo Pirozzi, Naohiro Okano, et al.
JCO Global Oncology|March 24, 2025
Overcoming Financial and Access Barriers in Global Cancer Care With Low-Dose Immunotherapy: A Systematic ReviewCeline Hoyek, Binbin Zheng-Lin, Jennah J Bauernfeind, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2026
Improving Affordability in Cancer Care for Resource-Limited Settings: Highlights From <i>JCO Global Oncology</i>Long Thanh Nguyen, Celine Hoyek, Akhil Kapoor, et al.
Expert Opinion on Drug Safety|May 1, 2025
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC)Angelo Pirozzi, Celine Hoyek, Naohiro Okano, et al.
Journal of Gastrointestinal Oncology|July 17, 2025
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case reportAngelo Pirozzi, Celine Hoyek, Oluseyi Abidoye, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 29, 2025
Evaluating third-line therapies in refractory metastatic colorectal cancer: a systematic review and network meta-analysisCeline Hoyek, Syed Arsalan Ahmed Naqvi, Oudai Sahvan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-095: Baseline Genomic Alterations as Predictors of Response to Anti-HER2 Therapy in HER2-Amplified Advanced Colorectal Cancer (aCRC)Celine Hoyek, Angelo Pirozzi, Binbin Zheng, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Targeting RAS in gastrointestinal malignanciesOluseyi Abidoye, Celine Hoyek, Tanios Bekaii-Saab
Expert Opinion on Investigational Drugs|February 28, 2025
Tucatinib in the treatment of HER2-overexpressing gastrointestinal cancers: current insights and future prospectsCeline Hoyek, Binbin Zheng-Lin, Jeremy Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 4, 2026
Successful Management of BRAF V600E-Mutated Metastatic Colorectal Cancer With Liver Dysfunction Using Encorafenib-Based TherapyCeline Hoyek, Angelo Pirozzi, Kelley Rone, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence?Celine Hoyek, Angelo Pirozzi, Naohiro Okano, et al.
JCO Global Oncology|March 24, 2025
Overcoming Financial and Access Barriers in Global Cancer Care With Low-Dose Immunotherapy: A Systematic ReviewCeline Hoyek, Binbin Zheng-Lin, Jennah J Bauernfeind, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2026
Improving Affordability in Cancer Care for Resource-Limited Settings: Highlights From <i>JCO Global Oncology</i>Long Thanh Nguyen, Celine Hoyek, Akhil Kapoor, et al.
Expert Opinion on Drug Safety|May 1, 2025
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC)Angelo Pirozzi, Celine Hoyek, Naohiro Okano, et al.
Journal of Gastrointestinal Oncology|July 17, 2025
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case reportAngelo Pirozzi, Celine Hoyek, Oluseyi Abidoye, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 29, 2025
Evaluating third-line therapies in refractory metastatic colorectal cancer: a systematic review and network meta-analysisCeline Hoyek, Syed Arsalan Ahmed Naqvi, Oudai Sahvan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-095: Baseline Genomic Alterations as Predictors of Response to Anti-HER2 Therapy in HER2-Amplified Advanced Colorectal Cancer (aCRC)Celine Hoyek, Angelo Pirozzi, Binbin Zheng, et al.
Pageof 2